pyridinolcarbamate has been researched along with Gout in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Gout: Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schettler, G | 1 |
1 other study available for pyridinolcarbamate and Gout
| Article | Year |
|---|---|
[Undesirable effects of hypolipemic drugs].
Topics: Adult; Arrhythmias, Cardiac; Avitaminosis; Biliary Tract Diseases; Cholestyramine Resin; Clofibrate; | 1980 |